Zhengrong Cui

Title: Innovator Zhengrong Cui: Pioneering Advances in HIV Vaccine Development

Introduction

Zhengrong Cui is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of medical research, particularly in the development of vaccines against human immunodeficiency virus (HIV). His innovative work has the potential to impact the lives of many individuals affected by this virus.

Latest Patents

Zhengrong Cui holds a patent for "Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticles." This patent describes a non-denatured, recombinant HIV Tat that is free of bacterial RNA and endotoxin, which is employed in an anti-HIV vaccine. The process of producing the recombinant Tat protein includes steps for removing bacterial RNA and endotoxin. Additionally, the patent outlines a Tat-adsorbed nanoparticle formulation and method of making the same. The method of vaccinating against and/or treating HIV infection involves administering an immune-response inducing effective amount of the recombinant Tat protein to a subject in need.

Career Highlights

Zhengrong Cui is affiliated with the University of Kentucky Research Foundation, where he conducts his research and development work. His dedication to advancing medical science is evident in his innovative approaches to vaccine development.

Collaborations

Zhengrong Cui has collaborated with esteemed colleagues such as Russell John Mumper and Jerold Woodward. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments for HIV.

Conclusion

Zhengrong Cui's contributions to HIV vaccine development exemplify the importance of innovation in medical research. His work not only advances scientific knowledge but also holds promise for improving public health outcomes.